Supplements

Why Are My Periods Getting Heavier in My Forties?

Heavy periods in your forties aren't just inconvenient — they're a common but frequently misunderstood hormonal shift. For most women, the culprit is a change in the estrogen-to-progesterone ratio that begins years before the final menstrual period. Understanding what's driving it makes targeted support possible.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
perimenopauseheavy periodsestrogen dominanceprogesteronehormonal balancewomen's health
Why Are My Periods Getting Heavier in My Forties?

Why Are My Periods Getting Heavier in My Forties?

For most women in their forties, heavier periods are a direct result of perimenopause-driven progesterone decline, which allows estrogen to act largely unopposed — a state called estrogen dominance. The main caveat: thyroid dysfunction, fibroids, and iron deficiency can all amplify the pattern, so a single hormonal explanation is rarely the whole picture. Women who are already managing a diagnosed condition like endometriosis or PCOS may find the shift arrives earlier and more severely.

---

What Actually Changes in Your Hormone Levels After 40

The transition into perimenopause is not a single event — it is a multi-year process, typically beginning anywhere from the late thirties to the mid-forties, during which ovulation becomes irregular. Irregular ovulation is the central issue. When you do not ovulate, your body does not produce a corpus luteum, and without a corpus luteum, progesterone production in the second half of your cycle plummets.

Estrogen, meanwhile, remains relatively robust — sometimes even spiking erratically before it eventually declines. The result is a lopsided hormonal environment in which estrogen stimulates the uterine lining to grow thicker than usual, but progesterone is not present in sufficient amounts to stabilize or shed it in an orderly way. When the lining finally does shed, the bleed is heavier, longer, and often clottier than it was in your twenties or thirties.

A landmark analysis of menstrual changes across the menopausal transition found that cycles in the late reproductive stage are characterized by significantly more variability and increased menstrual blood loss compared to peak reproductive years (Harlow et al., 2012; PMID: 22367889). This is not pathology in isolation — it is biology — but it does warrant attention, especially when the bleeding is impairing quality of life or driving iron loss.

If you are wondering whether what you are experiencing might already be perimenopause, the hormonal timeline, symptom clusters, and diagnostic criteria are explained in detail at how to tell if you are in perimenopause.

---

Why Heavy Bleeding and Worsening Metabolic Numbers Often Arrive Together

Many women in their forties notice something strange: at the same time their periods intensify, their fasting glucose, insulin, or cholesterol numbers start drifting in the wrong direction. This is not a coincidence.

Estrogen has a direct influence on insulin sensitivity. As estrogen levels become erratic during perimenopause, glucose metabolism can become less efficient, pushing fasting insulin higher even without major changes to diet or activity level. Higher insulin, in turn, promotes more fat storage in visceral tissue, which is itself hormonally active — producing additional estrogen and inflammatory signals that can worsen both the bleeding and the metabolic picture.

If your fasting insulin number is moving out of range and you can't pinpoint why, this hormonal interplay is a highly plausible explanation that often goes unaddressed in standard care. Similarly, perimenopausal estrogen shifts influence LDL particle behavior and ApoB, which is why cardiovascular risk profiles can change in this decade in ways that feel disconnected from lifestyle. Understanding what causes ApoB to drift out of range is worth exploring alongside the hormonal work-up.

The metabolic and hormonal systems are not separate. They are the same system viewed from different angles.

---

Five Specific Drivers Worth Investigating

Beyond the broad estrogen-progesterone shift, several distinct mechanisms can make heavy bleeding worse. A thorough evaluation should rule each of these in or out before settling on a plan.

1. Submucosal Fibroids

Uterine fibroids, benign smooth-muscle tumors, affect an estimated 70–80% of women by age 50, with Black women experiencing earlier onset and greater severity (Stewart et al., 2017; PMID: 28428139). Fibroids that encroach on the uterine cavity (submucosal type) disproportionately increase menstrual blood loss, sometimes dramatically. Diagnosis requires ultrasound, not just a symptom checklist.

2. Adenomyosis

Adenomyosis occurs when endometrial tissue grows into the muscular wall of the uterus. It causes heavy, painful, prolonged periods and tends to worsen in the perimenopausal years because it is estrogen-sensitive. Prevalence estimates vary widely (10–35% of women), and it is frequently diagnosed late or missed entirely. If you are curious about a related condition, the diagnostic features that distinguish adenomyosis from endometriosis are covered in how to know if you have endometriosis.

3. Thyroid Dysfunction

Hypothyroidism is strongly associated with menorrhagia. Thyroid hormone regulates clotting factor production; when thyroid output falls, coagulation can become impaired, leading to heavier periods. A TSH check — and ideally a free T3, free T4, and anti-TPO antibody panel — belongs in any work-up for new-onset heavy bleeding in the forties.

4. Coagulation Disorders

Von Willebrand disease, the most common inherited bleeding disorder, is frequently undiagnosed in women and often not identified until periods intensify in adulthood. If heavy bleeding has been a lifelong pattern rather than a new development, a hematology referral is appropriate.

5. Iron Deficiency Creating a Feedback Loop

This is one of the more underappreciated mechanisms: heavy bleeding depletes iron stores, and iron deficiency itself impairs platelet aggregation and clotting, which can worsen the bleeding in subsequent cycles. The cycle reinforces itself. Checking serum ferritin — not just hemoglobin — is essential, because ferritin can be severely depleted long before anemia is clinically apparent.

---

What Lab Work Actually Helps

A symptom-only approach to heavy periods in the forties leaves too many drivers unexamined. The following panel is a reasonable starting point:

Lab MarkerWhy It Matters in This Context
FSH, LHElevated FSH supports perimenopausal staging
Estradiol (day 3)Baseline estrogen assessment
Progesterone (day 21)Confirms whether ovulation is occurring
TSH, Free T3, Free T4Rules out thyroid-driven menorrhagia
Serum ferritinIron loss from heavy bleeding; target >50 ng/mL
Fasting insulin + glucoseMetabolic co-driver of estrogen dominance
ApoB or LDL-PCardiovascular shift tracking in perimenopause
CBC with plateletsBaseline hematology; clotting context

Results from this panel — particularly when combined with wearable data on sleep quality, HRV, and activity — give a far more actionable picture than any single marker alone.

---

Nutritional and Supplement Strategies Backed by Evidence

While clinical management of fibroids or adenomyosis ultimately requires a gynecologist, nutritional and supplement interventions can meaningfully support hormonal balance, reduce inflammation, and address the iron depletion that often accompanies heavy bleeding.

Vitex (Chasteberry)

Vitex agnus-castus has the most consistent clinical evidence for supporting progesterone-dominant activity in perimenopause-related cycle irregularity. A double-blind, placebo-controlled trial of 178 women with premenstrual symptoms found significant improvement in the Vitex arm compared to placebo (Schellenberg et al., 2012; PMID: 22972105). The proposed mechanism involves dopaminergic action on the pituitary, which reduces excess prolactin and supports LH pulsatility — both of which can support corpus luteum function and progesterone output.

DIM (Diindolylmethane)

DIM is a compound derived from cruciferous vegetables that modulates estrogen metabolism, specifically promoting the conversion of estrogen to the less proliferative 2-hydroxyestrone pathway rather than the more potent 16-alpha pathway. This shift is associated with lower estrogen dominance signaling. Research in women with estrogen-sensitive conditions supports DIM's role in shifting the 2:16 hydroxyestrone ratio favorably (Dalessandri et al., 2004; PMID: 15623462).

Omega-3 Fatty Acids (EPA/DHA)

Prostaglandin imbalance — specifically an excess of pro-inflammatory series-2 prostaglandins — is a recognized driver of heavy, painful menstruation. Omega-3 fatty acids shift the eicosanoid balance toward less inflammatory series-3 prostaglandins. A randomized controlled trial in adolescents with primary dysmenorrhea found that fish oil supplementation significantly reduced pain scores and systemic NSAID use (Harel et al., 1996; PMID: 8598625). While the population was younger, the prostaglandin mechanism is not age-dependent.

Iron Bisglycinate

For replenishing the iron lost through heavy cycles, iron bisglycinate is absorbed significantly better than ferrous sulfate and causes substantially less gastrointestinal distress — a common reason women discontinue supplementation. Maintaining ferritin above 50 ng/mL is the functional target; below 30 ng/mL is associated with fatigue, poor thermoregulation, and hair shedding even in the absence of overt anemia.

Magnesium

Magnesium deficiency is extremely common in women experiencing perimenopausal stress and sleep disruption, and magnesium plays a direct role in regulating prostaglandin synthesis and reducing uterine cramping. Magnesium glycinate is the most bioavailable and best-tolerated form for ongoing supplementation.

---

What This Means for Your Formula

The hormonal, metabolic, and inflammatory drivers of heavy perimenopausal periods interact in ways that make a blanket supplement protocol largely ineffective. What matters is knowing which levers are actually out of range for you specifically.

Ones builds personalized daily capsule formulas by analyzing your lab results, wearable data, and health history through an AI health practitioner framework. For someone presenting with perimenopausal heavy bleeding, the relevant ingredients might include:

  • Omega-3 (EPA/DHA) at clinically meaningful doses to shift prostaglandin balance away from the inflammatory series-2 pathway — the mechanism documented in dysmenorrhea trials
  • Ones Endocrine Support (a proprietary blend targeting hormonal axis regulation), which may be appropriate when lab results indicate estrogen-to-progesterone imbalance or irregular ovulation patterns
  • Ones Adrenal Support, relevant when cortisol dysregulation is contributing to progesterone steal — a common secondary driver in women experiencing high allostatic load in their forties

The formula is calibrated to a 6 or 9-capsule daily plan based on what the AI identifies as your specific findings, not a one-size-fits-all hormonal supplement stack. That distinction matters because DIM, Vitex, and iron bisglycinate, for example, each have different indications depending on where your numbers actually sit.

---

Key Takeaways

  • Progesterone decline during perimenopause is the primary driver of heavier periods in the forties — erratic ovulation means less progesterone to stabilize a thicker estrogen-driven uterine lining.
  • Structural causes matter: fibroids and adenomyosis are common and frequently overlooked; ultrasound is necessary for a complete picture, not just symptom review.
  • The hormonal and metabolic shifts are connected: worsening fasting insulin, ApoB drift, and heavy periods often share the same perimenopausal root and deserve to be investigated together.
  • Iron depletion and heavy bleeding form a feedback loop — heavy bleeding causes iron loss, and iron deficiency impairs clotting, worsening subsequent cycles. Ferritin, not just hemoglobin, must be checked.
  • Targeted supplements — DIM, Vitex, omega-3s, and magnesium — have evidence for supporting estrogen metabolism, prostaglandin balance, and cycle regulation, but their appropriateness depends on your individual lab and symptom pattern.
  • A blood panel combined with wearable data gives the clearest picture: FSH, estradiol, day-21 progesterone, TSH, ferritin, and fasting insulin together map the terrain far better than any single marker.

---

This article is for informational purposes only and does not constitute medical advice. Heavy menstrual bleeding can have serious underlying causes. Please consult a qualified healthcare provider for evaluation and treatment.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading